Table 1 Baseline characteristics
TAE ( n =42) | sTACE ( n =44) | |
|---|---|---|
Age | ||
Median (range) | 62.6 (30.7, 85.2) | 63.2 (44.1, 79.3) |
Gender | ||
Male | 35 (83.3) | 39 (88.6) |
Female | 7 (16.7) | 5 (11.4) |
Child Pugh status | ||
A | 33 (78.6) | 38 (86.4) |
B | 9 (21.4) | 6 (13.6) |
ECOG PS | ||
0 | 27 (64.3) | 31 (70.5) |
1 | 9 (21.4) | 8 (18.2) |
2 | 6 (14.3) | 5 (11.4) |
Ascites | ||
Absent | 38 (90.5) | 35 (79.5) |
Slight | 3 (7.1) | 7 (15.9) |
Moderate | 1 (2.4) | 1 (2.3) |
Unknown | 0 | 1 (2.3) |
Hepatitis B | ||
Absent | 37 ( 88.1) | 34 (77.3) |
Present | 5 (11.9) | 9 (20.5) |
Unknown | 0 | 1 (2.3) |
Hepatitis C | ||
Absent | 23 (54.8) | 27 (61.4) |
Present | 19 (45.2) | 16 (36.4) |
Unknown | 0 (0.0) | 1 (2.3) |
Alcohol disease | ||
Absent | 37 (88.1) | 30 (68.2) |
Present | 5 (11.9) | 13 (29.5) |
Unknown | 0 | 1 (2.3) |
Disease focality | ||
Unifocal | 13 (31.0) | 15 (34.1) |
Multifocal: 2 nodules | 7 (16.7) | 12 (27.3) |
Multifocal: >2 nodules | 16 (38.1) | 14 (31.8) |
Diffuse | 3 (7.1) | 2 (4.5) |
Multifocal: number unknown | 3 (7.1) | 1 (2.3) |
Liver volume occupied by tumour | ||
⩽50% | 36 (85.7) | 36 (81.8) |
>50% | 2 (4.8) | 0 |
Unknown | 4 (9.5) | 8 (18.2) |
Disease extent | ||
Unilobar | 21 (50.0) | 21 (47.7) |
Bilobar | 16 (38.1) | 15 (34.1) |
Unknown | 5 (11.9) | 8 (18.2) |
Baseline AFP (ng ml−1) | ||
⩽400 | 32 (76.2) | 33 (75.0) |
>400 | 10 (23.8) | 11 (25.0) |
Size of largest nodule | ||
⩽7 cm | 28 (66.7) | 37 (84.1) |
>7 cm | 14 (33.3) | 7 (15.9) |
Okuda score | ||
I | 25 (59.5) | 22 (50.0) |
II | 8 (19.0) | 10 (22.7) |
Unknown | 9 (21.4) | 12 (27.3) |
CLIP Score | ||
0 | 6 (14.3) | 9 (20.5) |
1 | 17 (40.5) | 16 ( 36.4) |
2 | 9 (21.4) | 7 (15.9) |
3 | 2 (4.8) | 1 (2.3) |
Unknown | 8 (19.0) | 11 (25.0) |
French score | ||
A | 16 (38.1) | 20 (45.5) |
B | 18 (42.9) | 19 (43.2) |
Unknown | 8 (19.0) | 5 (11.4) |
BCLC score | ||
A | 9 (21.4) | 11 (25.0) |
B | 16 (38.1) | 18 (40.9) |
C | 15 (35.7) | 12 (27.3) |
Unknown | 2 (4.8) | 3 (6.8) |
